Mesenteric artery bypass: objective patency determination. 1995

W D McMillan, and W J McCarthy, and M R Bresticker, and W H Pearce, and J R Schneider, and J F Golan, and J S Yao
Department of Surgery, McGaw Medical Center, Northwestern University Medical School, Chicago, IL, USA.

OBJECTIVE Many authors have reported extended relief of intestinal ischemia by use of a variety of reconstructive techniques, but all have relied on symptomatic follow-up. None have objectively measured patency rates. The purpose of this study was to determine the primary patency rates of bypass grafts placed for acute and chronic splanchnic atherosclerotic occlusive disease with use of objective follow-up with mesenteric duplex ultrasound scanning or arteriography. METHODS Twenty-five consecutive patients (mean age 61, female/male ratio of 2.7:1) who underwent placement of 38 splanchnic bypass grafts (29 saphenous vein grafts, 9 polytetrafluoroethylene) (22 retrograde, 16 antegrade) for ischemic symptoms (9 acute ischemia: 16 chronic ischemia) between 1984 and 1994 were monitored with either duplex scanning (30 grafts) or arteriography. Life-table and log rank analysis were used to determine and compare graft patency. RESULTS Three patients (12%, 2 acute ischemia and 1 chronic ischemia) died after operation. Six patients (30%) had significant morbidity (4 acute ischemia and 2 chronic ischemia). During follow-up from 1 to 136 months (mean 35 months), no patient died of bowel infarction or required revision for recurrent symptoms. Objective testing revealed three graft occlusions. Symptomatic follow-up had a sensitivity of only 33% for graft occlusion when compared with objective measurement. The life-table primary patency rate was 89% at 72 months. Life-table survival for the same patients was 75% at 36 months. Patency rates for antegrade (93% at 36 months) versus retrograde (95% at 36 months) bypass and saphenous vein grafts (95% at 36 months) versus polytetrafluoroethylene (89% at 36 months) were not significantly different (p = 0.47 and 0.43, respectively). Late patency rates of grafts placed for acute ischemia (92% at 36 months) versus chronic ischemia (89% at 36 months) were not significantly different (p = 0.77). CONCLUSIONS Splanchnic bypass for mesenteric ischemia, with a primary patency rate of 89% at 72 months, is an extremely durable form of revascularization. Long-term patency of grafts placed for acute ischemia does not differ significantly from that of bypasses for chronic occlusion. Duplex scanning allows standardized objective periodic follow-up of splanchnic reconstruction. Objective assessment is critical to accurately measure visceral revascularization patency rates.

UI MeSH Term Description Entries
D007511 Ischemia A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION. Ischemias
D008297 Male Males
D008638 Mesenteric Arteries Arteries which arise from the abdominal aorta and distribute to most of the intestines. Arteries, Mesenteric,Artery, Mesenteric,Mesenteric Artery
D008641 Mesenteric Vascular Occlusion Obstruction of the flow in the SPLANCHNIC CIRCULATION by ATHEROSCLEROSIS; EMBOLISM; THROMBOSIS; STENOSIS; TRAUMA; and compression or intrinsic pressure from adjacent tumors. Rare causes are drugs, intestinal parasites, and vascular immunoinflammatory diseases such as PERIARTERITIS NODOSA and THROMBOANGIITIS OBLITERANS. (From Juergens et al., Peripheral Vascular Diseases, 5th ed, pp295-6) Mesenteric Vascular Occlusions,Occlusion, Mesenteric Vascular,Occlusions, Mesenteric Vascular,Vascular Occlusion, Mesenteric,Vascular Occlusions, Mesenteric
D008643 Mesentery A layer of the peritoneum which attaches the abdominal viscera to the ABDOMINAL WALL and conveys their blood vessels and nerves. Mesenteries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011138 Polytetrafluoroethylene Homopolymer of tetrafluoroethylene. Nonflammable, tough, inert plastic tubing or sheeting; used to line vessels, insulate, protect or lubricate apparatus; also as filter, coating for surgical implants or as prosthetic material. Synonyms: Fluoroflex; Fluoroplast; Ftoroplast; Halon; Polyfene; PTFE; Tetron. FEP,Fluon,Politef,Polytef,TFE,Teflon,Expanded PTFE,Fluoroplast,GORE-TEX,Goretex,PTFE,Tarflen,GORE TEX,PTFE, Expanded
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001807 Blood Vessel Prosthesis Device constructed of either synthetic or biological material that is used for the repair of injured or diseased blood vessels. Vascular Prosthesis,Blood Vessel Prostheses,Tissue-Engineered Vascular Graft,Graft, Tissue-Engineered Vascular,Grafts, Tissue-Engineered Vascular,Prostheses, Blood Vessel,Prostheses, Vascular,Prosthesis, Blood Vessel,Prosthesis, Vascular,Tissue Engineered Vascular Graft,Tissue-Engineered Vascular Grafts,Vascular Graft, Tissue-Engineered,Vascular Grafts, Tissue-Engineered,Vascular Prostheses,Vessel Prostheses, Blood,Vessel Prosthesis, Blood

Related Publications

W D McMillan, and W J McCarthy, and M R Bresticker, and W H Pearce, and J R Schneider, and J F Golan, and J S Yao
April 1958, Zeitschrift fur Laryngologie, Rhinologie, Otologie und ihre Grenzgebiete,
W D McMillan, and W J McCarthy, and M R Bresticker, and W H Pearce, and J R Schneider, and J F Golan, and J S Yao
December 2010, Journal of vascular and interventional radiology : JVIR,
W D McMillan, and W J McCarthy, and M R Bresticker, and W H Pearce, and J R Schneider, and J F Golan, and J S Yao
January 2014, Revista portuguesa de cirurgia cardio-toracica e vascular : orgao oficial da Sociedade Portuguesa de Cirurgia Cardio-Toracica e Vascular,
W D McMillan, and W J McCarthy, and M R Bresticker, and W H Pearce, and J R Schneider, and J F Golan, and J S Yao
December 1989, Circulation,
W D McMillan, and W J McCarthy, and M R Bresticker, and W H Pearce, and J R Schneider, and J F Golan, and J S Yao
September 2009, The Journal of thoracic and cardiovascular surgery,
W D McMillan, and W J McCarthy, and M R Bresticker, and W H Pearce, and J R Schneider, and J F Golan, and J S Yao
July 2014, JACC. Cardiovascular interventions,
W D McMillan, and W J McCarthy, and M R Bresticker, and W H Pearce, and J R Schneider, and J F Golan, and J S Yao
December 1994, Cardiovascular surgery (London, England),
W D McMillan, and W J McCarthy, and M R Bresticker, and W H Pearce, and J R Schneider, and J F Golan, and J S Yao
April 2003, Nihon rinsho. Japanese journal of clinical medicine,
W D McMillan, and W J McCarthy, and M R Bresticker, and W H Pearce, and J R Schneider, and J F Golan, and J S Yao
March 1988, European heart journal,
W D McMillan, and W J McCarthy, and M R Bresticker, and W H Pearce, and J R Schneider, and J F Golan, and J S Yao
March 2024, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery,
Copied contents to your clipboard!